The impact of perioperative transfusions on the oncologic outcomes of patients with ovarian cancer: a population-based study
Bouchard-Fortier G, Gien LT, Chan WC, Lin Y, Krzyzanowska MK, Ferguson SE. J Surg Oncol. 2024; Aug 27 [Epub ahead of print].
Purpose — Evidence suggests that women with type 2 diabetes may be at increased risk of breast cancer, possibly due to chronic exposure to insulin resistance and/or hyperinsulinemia. The purpose of this study was to compare the incidence of breast cancer in postmenopausal women with and without diabetes.
Methods — Using population-based validated health databases from Ontario, Canada, this retrospective cohort study compared breast cancer incidence between women, aged 55–79 years, with newly diagnosed diabetes (n=73,796) to women without diabetes (n=391,714).
Results — Women with diabetes were slightly older, were more likely to reside in a lower income neighborhood, had greater comorbidity, and had more annual physician visits than women without diabetes. After 2.2 million person-years of follow-up from 1994 to 2002, breast cancer incidence was 2.97/1000 person-years in the diabetes group and 2.75/1000 person-years in the non-diabetes group. After adjustment for age and income, there was a significant increase in breast cancer among women with diabetes (hazard ratio, HR, 1.08, 95% confidence interval, CI, 1.01–1.16, p=0.021).
Conclusion — This study found a small but significant increase in incident breast cancer in a predominantly postmenopausal population of women with diabetes, when compared to women without diabetes. These results support the possibility that insulin resistance or some other aspect of type 2 diabetes may promote breast cancer, and may further direct treatment and prevention strategies.
Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Breast Cancer Res Treat. 2006; 98(3):349-56. Epub 2006 Mar 16.
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.